Finally, limited data are available about other maternal risk factors for birth defects, including genetic or other infectious causes, which might be causal factors for a few of the birth defects reported here. Identification and follow-up care of infants born to mothers with laboratory evidence of possible recent Zika virus infection during pregnancy and infants with possible congenital Zika virus infection can ensure that appropriate intervention services are available to affected infants. If there is concern about infant follow-up or maternal testing is not performed, infant Zika virus testing should be considered. For this reason, in this report, analysis of the subset of pregnancies with laboratory-confirmed recent Zika virus infection was included. Pregnant women with Zika virus exposure and prenatally detected fetal abnormalities or infants with birth defects might be more likely to be tested for Zika virus infection.
French pharma rejects U.S. request for fair price for Zika vaccine
Zika is transmitted primarily by the bite of an infected Aedes aegypti mosquito, pictured here. scientists with the Walter Reed Army Institute of Research (WRAIR) launched early stage clinical trials in November that they hope will lead to the development of a vaccine against the virus. But an exclusive deal for Sanofi Pasteur, granted by the U.S. Army, has angered lawmakers who say the company will be able to charge whatever price it wants when a vaccine is developed.
collected by :Lucy William
No comments:
Post a Comment